These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26348948)

  • 21. BMS in microbiome immuno-oncology deal.
    Nat Biotechnol; 2017 Jan; 35(1):5. PubMed ID: 28072775
    [No Abstract]   [Full Text] [Related]  

  • 22. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 23. Biogen Idec restructures, sharpens neurology focus.
    Mitchell P
    Nat Biotechnol; 2011 Jan; 29(1):7-8. PubMed ID: 21221080
    [No Abstract]   [Full Text] [Related]  

  • 24. Agbiotech climbs Africa's agenda.
    Fox JL
    Nat Biotechnol; 2003 Jun; 21(6):589. PubMed ID: 12776132
    [No Abstract]   [Full Text] [Related]  

  • 25. Showcasing bioscience in Rhode Island.
    Spero D
    R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The current state of bioeconomy in Poland.
    Woźniak E; Twardowski T
    Acta Biochim Pol; 2016; 63(4):731-735. PubMed ID: 27801431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interview with John W. Kozarich, PhD. Interview by Vicki Glaser.
    Kozarich JW
    Assay Drug Dev Technol; 2013 Jun; 11(5):283-8. PubMed ID: 23772549
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissecting monoclonal antibody mega-deals.
    Villiger R; Bogdan B
    MAbs; 2009; 1(2):172-8. PubMed ID: 20061828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics and the world's economy.
    Enríquez J
    Science; 1998 Aug; 281(5379):925-6. PubMed ID: 9722465
    [No Abstract]   [Full Text] [Related]  

  • 30. Is academic medicine for sale?
    Angell M
    N Engl J Med; 2000 May; 342(20):1516-8. PubMed ID: 10816191
    [No Abstract]   [Full Text] [Related]  

  • 31. Fallout from the merger that might be.
    Hodgson J
    Nat Biotechnol; 1999 Jan; 17(1):15-6. PubMed ID: 9920254
    [No Abstract]   [Full Text] [Related]  

  • 32. Demise of the life science company begins.
    Niiler E
    Nat Biotechnol; 2000 Jan; 18(1):14. PubMed ID: 10625374
    [No Abstract]   [Full Text] [Related]  

  • 33. India: 50 years after independence.
    Miller DD; Nayak AR
    Nat Biotechnol; 1997 Aug; 15(8):727-9. PubMed ID: 9255782
    [No Abstract]   [Full Text] [Related]  

  • 34. Barnyard biotech--lame duck or golden goose?
    Powell K
    Nat Biotechnol; 2003 Sep; 21(9):965-7. PubMed ID: 12949546
    [No Abstract]   [Full Text] [Related]  

  • 35. Around the world in a month.
    Nat Biotechnol; 2016 Feb; 34(2):125. PubMed ID: 26849506
    [No Abstract]   [Full Text] [Related]  

  • 36. The commercial development of gene therapy in Europe and the USA.
    Martin PA; Thomas SM
    Hum Gene Ther; 1998 Jan; 9(1):87-114. PubMed ID: 9458246
    [No Abstract]   [Full Text] [Related]  

  • 37. Biotechnology patenting: the wicked animal must defend itself.
    Crespi S
    Eur Intellect Prop Rev; 1995 Sep; 17(9):431-41. PubMed ID: 11654979
    [No Abstract]   [Full Text] [Related]  

  • 38. The brave new world of animal biotechnology. Project report.
    Donnelley S; McCarthy CR; Singleton R
    Hastings Cent Rep; 1994; 24(1 Suppl):S1-31. PubMed ID: 11654088
    [No Abstract]   [Full Text] [Related]  

  • 39. Mike Varney.
    Varney M; Mullard A
    Nat Rev Drug Discov; 2015 Mar; 14(3):158-9. PubMed ID: 25677359
    [No Abstract]   [Full Text] [Related]  

  • 40. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry.
    Smaglik P; Frantz S
    Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.